Navigation Links
Kendle to Present at Robert Baird 2009 Health Care Conference
Date:9/3/2009

CINCINNATI, Sept. 3 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the Company will participate in the upcoming Robert Baird 2009 Health Care Conference on Sept. 10, 2009 at the Four Seasons Hotel New York in New York City.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO )

Kendle's formal presentation will be given by Senior Vice President and Chief Marketing Officer Simon Higginbotham and Senior Vice President and Chief Financial Officer Keith Cheesman at 2:45 p.m. Eastern Time.

The presentation will be Webcast and may be accessed at www.kendle.com in the "Investors Events & Presentations" section or at http://www.wsw.com/webcast/baird9/kndl/.

Slides will be available by 11 a.m. on the day of the presentation at www.kendle.com in the "Investors Events & Presentations" section.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate
'/>"/>

SOURCE Kendle International Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
2. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
3. Kendle to Present at Thomas Weisel Partners Healthcare Conference 2007
4. Kendle to Present at Bear Stearns 20th Annual Healthcare Conference
5. Kendle to Present at the UBS Global Life Sciences Conference
6. Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference
7. Kendle Invites You to Attend Its Third Quarter 2007 Earnings Conference Call and Webcast
8. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
9. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
10. Kendle to Present at the Wachovia 2008 Healthcare Conference
11. Kendle Hires Satish Tripathi, PhD, RAC as Vice President, Global Regulatory and Quality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 VG ... strategic alliance with DAK Renewable Research to conduct ... oil yield. VG Energy is a majority owned ... VGLS). VG Energy,s exclusively licensed compound ... the oil yield in plants, possessing a wide ...
(Date:5/23/2013)... 2013 BioTrends Research Group, one of ... specialized biopharmaceutical issues, finds that, unaided, one in ... reported that in the past six months, they ... in anticipation of the next generation of HCV ... only 6 percent reported that they had begun ...
(Date:5/23/2013)... , May 23, 2013 Northwest Biotherapeutics (NASDAQ: ... developing DCVax ® personalized immune therapies for solid ... exhibit at this year,s American Society Of Clinical Oncology ... highlight its leadership role in immune therapy.  ... annual meeting is the pre-eminent conference focused on clinical ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013  Verenium ... biotechnology company focused on the development and commercialization of ... , Chief Financial Officer, will present at two ... Mr. Black will present at the Second Annual ... at the Grand Hyatt Hotel in New York City.  ...
Breaking Biology Technology:VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3
... the revival of an ancient eco-friendly building technique, according to ... at Durham,s School of Engineering, have carried out a study ... popularity as a sustainable building method. Just as a ... engineers found that the strength of rammed earth was heavily ...
... SFARI Base to Usher in ,New Paradigm of Research ... Prometheus Research has signed a three year contract ... development partnership on SFARI Base, the HTSQL-based informatics platform ... autism. The collaboration is part of the Simons Foundation ...
... Proplant Inc. announced today it has been awarded an EPC ... plants Steam Integration Project. QAFCO operates the world,s largest ... Proplant will perform engineering, procurement and construction for this ... project includes tying in a new cogeneration steam production plant ...
Cached Biology Technology:Secret of sandcastle construction could help revive ancient building technique, researchers say 2Secret of sandcastle construction could help revive ancient building technique, researchers say 3Prometheus Research Signs 3-Year Contract With Simons Foundation to Expand HTSQL Informatics System for Autism Research 2
(Date:5/24/2013)... Modulating the immune system to combat metastatic cancer ... and destruction by the immune system. Stimulation of the ... there are many factors that cause the immune system ... cells that function to suppress the immune system response. ... Investigation , researchers led by Ronald Levy at Stanford ...
(Date:5/24/2013)... non-coding RNAs are small molecules that help control ... they have emerged as disease biomarkers. miRNA profiles ... cancers of unknown primary origin, determine prognosis, monitor ... tractable, diagnostic methods for monitoring miRNA expression in ... issue of the Journal of Clinical Investigation ...
(Date:5/24/2013)... Alzheimer,s disease, scientists have focused among other factors ... all, it is the accumulation of A-beta that causes the ... for the formation of A-beta is APP. Alessia Soldano and ... function of APPL the fruit-fly version of APP ... Soldano (VIB/KU Leuven): "We have discovered that APPL ensures that ...
Breaking Biology News(10 mins):JCI early table of contents for May 24, 2013 2JCI early table of contents for May 24, 2013 3JCI early table of contents for May 24, 2013 4JCI early table of contents for May 24, 2013 5JCI early table of contents for May 24, 2013 6JCI early table of contents for May 24, 2013 7JCI early table of contents for May 24, 2013 8A new strategy required in the search for Alzheimer's drugs? 2
... , ORLANDO, Fla., June 26 Consuming higher amounts ... heart disease risk for women with type 1 diabetes, ... Public Health study being presented at the 70th Scientific ... abstract number 1757-P, included 601 men and women enrolled ...
... The rediscovery of a fern, long thought to ... save the plants of the tiny UK overseas territory ... fitting success story during the UN,s International Year of ... from Ascension Island,s Conservation Department(2) decided to explore an ...
... diversity in a forest? It,s a question even Charles ... diversity demonstrates only patterns of species survival and abundance ... A team of researchers led by biologists at ... pathogens are one important mechanism that can maintain species ...
Cached Biology News:Ascension Island 'extinct' parsley fern rediscovered during International Year of Biodiversity 2Ascension Island 'extinct' parsley fern rediscovered during International Year of Biodiversity 3Ascension Island 'extinct' parsley fern rediscovered during International Year of Biodiversity 4Soil-borne pathogens drive tree diversity in forests, study shows 2